Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Recombinant antibodies are antibody fragments produced by synthetic genes. Recombinant antibodies are used in medical and research applications. Recombinant antibodies in different formats are used in human and pharmaceutical research and production.
The global recombinant antibody production market is divided into five key regions. North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. North America is expected to lead the global recombinant antibody production market. Europe also shows the second largest market in the recombinant antibody production market. The massive R&D expenditures in the development of new drugs in developed regions, coupled with the emergence of large companies in the fields of biotechnology and molecular science, are driving the growth of the recombinant antibody production market in North America and Europe. It is expected that the recombinant antibody production market in the Asia-Pacific region will see significant growth in the next few years.
Increasing research and development in the biopharmaceutical industry is expected to promote the growth of the recombinant antibody production market. Manufacturers are focusing on the production of new antibodies, which is expected to promote the growth of the recombinant antibody production market. The rapid growth of the biopharmaceutical industry is expected to create strong growth opportunities for the recombinant antibody production market. The high demand for recombinant antibodies in the diagnosis and treatment of various diseases is expected to drive the growth of the recombinant antibody production market. Recombinant antibodies have become a treatment for cancer, HIV, and herpes simplex virus. Compared with full-length IgG immunoglobulins, advantages such as better penetration in tumor tissues are expected to benefit the growing recombinant antibody production market.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Recombinant Antibody market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Recombinant Antibody market. Detailed analysis of key players, along with key growth strategies adopted by Recombinant Antibody industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
GE Healthcare
Abnova
Medix Biochemica
SinoBiological
Bioventix
By Type:
Single Chain Variable Fragment (scFv)
Fab Fragment
Bispecific Recombinant Antibodies (Diabodies)
By End-User:
Hospital
Scientific Research
Others
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Recombinant Antibody Market
-
1.3 Market Segment by Type
-
1.3.1 China Recombinant Antibody Market Size and Growth Rate of Single Chain Variable Fragment (scFv) from 2016 to 2027
-
1.3.2 China Recombinant Antibody Market Size and Growth Rate of Fab Fragment from 2016 to 2027
-
1.3.3 China Recombinant Antibody Market Size and Growth Rate of Bispecific Recombinant Antibodies (Diabodies) from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Recombinant Antibody Market Size and Growth Rate of Hospital from 2016 to 2027
-
1.4.2 China Recombinant Antibody Market Size and Growth Rate of Scientific Research from 2016 to 2027
-
1.4.3 China Recombinant Antibody Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Recombinant Antibody Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Recombinant Antibody Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Recombinant Antibody Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Recombinant Antibody Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Recombinant Antibody Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Recombinant Antibody Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Recombinant Antibody Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Recombinant Antibody Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Recombinant Antibody by Major Types
-
3.4.1 Market Size and Growth Rate of Single Chain Variable Fragment (scFv)
-
3.4.2 Market Size and Growth Rate of Fab Fragment
-
3.4.3 Market Size and Growth Rate of Bispecific Recombinant Antibodies (Diabodies)
4 Segmentation of Recombinant Antibody Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Recombinant Antibody by Major End-Users
-
4.4.1 Market Size and Growth Rate of Recombinant Antibody in Hospital
-
4.4.2 Market Size and Growth Rate of Recombinant Antibody in Scientific Research
-
4.4.3 Market Size and Growth Rate of Recombinant Antibody in Others
5 Market Analysis by Regions
-
5.1 China Recombinant Antibody Production Analysis by Regions
-
5.2 China Recombinant Antibody Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Recombinant Antibody Landscape Analysis
-
6.1 North China Recombinant Antibody Landscape Analysis by Major Types
-
6.2 North China Recombinant Antibody Landscape Analysis by Major End-Users
7 Central China Recombinant Antibody Landscape Analysis
-
7.1 Central China Recombinant Antibody Landscape Analysis by Major Types
-
7.2 Central China Recombinant Antibody Landscape Analysis by Major End-Users
8 South China Recombinant Antibody Landscape Analysis
-
8.1 South China Recombinant Antibody Landscape Analysis by Major Types
-
8.2 South China Recombinant Antibody Landscape Analysis by Major End-Users
9 East China Recombinant Antibody Landscape Analysis
-
9.1 East China Recombinant Antibody Landscape Analysis by Major Types
-
9.2 East China Recombinant Antibody Landscape Analysis by Major End-Users
10 Northeast China Recombinant Antibody Landscape Analysis
-
10.1 Northeast China Recombinant Antibody Landscape Analysis by Major Types
-
10.2 Northeast China Recombinant Antibody Landscape Analysis by Major End-Users
11 Southwest China Recombinant Antibody Landscape Analysis
-
11.1 Southwest China Recombinant Antibody Landscape Analysis by Major Types
-
11.2 Southwest China Recombinant Antibody Landscape Analysis by Major End-Users
12 Northwest China Recombinant Antibody Landscape Analysis
-
12.1 Northwest China Recombinant Antibody Landscape Analysis by Major Types
-
12.2 Northwest China Recombinant Antibody Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 GE Healthcare
-
13.1.1 GE Healthcare Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Abnova
-
13.2.1 Abnova Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Medix Biochemica
-
13.3.1 Medix Biochemica Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 SinoBiological
-
13.4.1 SinoBiological Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Bioventix
-
13.5.1 Bioventix Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Recombinant Antibody Market Size and Growth Rate of Single Chain Variable Fragment (scFv) from 2016 to 2027
-
Figure China Recombinant Antibody Market Size and Growth Rate of Fab Fragment from 2016 to 2027
-
Figure China Recombinant Antibody Market Size and Growth Rate of Bispecific Recombinant Antibodies (Diabodies) from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Recombinant Antibody Market Size and Growth Rate of Hospital from 2016 to 2027
-
Figure China Recombinant Antibody Market Size and Growth Rate of Scientific Research from 2016 to 2027
-
Figure China Recombinant Antibody Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Recombinant Antibody Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Recombinant Antibody Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Recombinant Antibody Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Recombinant Antibody Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Recombinant Antibody Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Recombinant Antibody Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Recombinant Antibody Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Recombinant Antibody Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Recombinant Antibody
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Recombinant Antibody by Different Types from 2016 to 2027
-
Table Consumption Share of Recombinant Antibody by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Single Chain Variable Fragment (scFv)
-
Figure Market Size and Growth Rate of Fab Fragment
-
Figure Market Size and Growth Rate of Bispecific Recombinant Antibodies (Diabodies)
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Recombinant Antibody by Different End-Users from 2016 to 2027
-
Table Consumption Share of Recombinant Antibody by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospital
-
Figure Market Size and Growth Rate of Scientific Research
-
Figure Market Size and Growth Rate of Others
-
Table China Recombinant Antibody Production by Regions
-
Table China Recombinant Antibody Production Share by Regions
-
Figure China Recombinant Antibody Production Share by Regions in 2016
-
Figure China Recombinant Antibody Production Share by Regions in 2021
-
Figure China Recombinant Antibody Production Share by Regions in 2027
-
Table China Recombinant Antibody Consumption by Regions
-
Table China Recombinant Antibody Consumption Share by Regions
-
Figure China Recombinant Antibody Consumption Share by Regions in 2016
-
Figure China Recombinant Antibody Consumption Share by Regions in 2021
-
Figure China Recombinant Antibody Consumption Share by Regions in 2027
-
Table North China Recombinant Antibody Consumption by Types from 2016 to 2027
-
Table North China Recombinant Antibody Consumption Share by Types from 2016 to 2027
-
Figure North China Recombinant Antibody Consumption Share by Types in 2016
-
Figure North China Recombinant Antibody Consumption Share by Types in 2021
-
Figure North China Recombinant Antibody Consumption Share by Types in 2027
-
Table North China Recombinant Antibody Consumption by End-Users from 2016 to 2027
-
Table North China Recombinant Antibody Consumption Share by End-Users from 2016 to 2027
-
Figure North China Recombinant Antibody Consumption Share by End-Users in 2016
-
Figure North China Recombinant Antibody Consumption Share by End-Users in 2021
-
Figure North China Recombinant Antibody Consumption Share by End-Users in 2027
-
Table Central China Recombinant Antibody Consumption by Types from 2016 to 2027
-
Table Central China Recombinant Antibody Consumption Share by Types from 2016 to 2027
-
Figure Central China Recombinant Antibody Consumption Share by Types in 2016
-
Figure Central China Recombinant Antibody Consumption Share by Types in 2021
-
Figure Central China Recombinant Antibody Consumption Share by Types in 2027
-
Table Central China Recombinant Antibody Consumption by End-Users from 2016 to 2027
-
Table Central China Recombinant Antibody Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Recombinant Antibody Consumption Share by End-Users in 2016
-
Figure Central China Recombinant Antibody Consumption Share by End-Users in 2021
-
Figure Central China Recombinant Antibody Consumption Share by End-Users in 2027
-
Table South China Recombinant Antibody Consumption by Types from 2016 to 2027
-
Table South China Recombinant Antibody Consumption Share by Types from 2016 to 2027
-
Figure South China Recombinant Antibody Consumption Share by Types in 2016
-
Figure South China Recombinant Antibody Consumption Share by Types in 2021
-
Figure South China Recombinant Antibody Consumption Share by Types in 2027
-
Table South China Recombinant Antibody Consumption by End-Users from 2016 to 2027
-
Table South China Recombinant Antibody Consumption Share by End-Users from 2016 to 2027
-
Figure South China Recombinant Antibody Consumption Share by End-Users in 2016
-
Figure South China Recombinant Antibody Consumption Share by End-Users in 2021
-
Figure South China Recombinant Antibody Consumption Share by End-Users in 2027
-
Table East China Recombinant Antibody Consumption by Types from 2016 to 2027
-
Table East China Recombinant Antibody Consumption Share by Types from 2016 to 2027
-
Figure East China Recombinant Antibody Consumption Share by Types in 2016
-
Figure East China Recombinant Antibody Consumption Share by Types in 2021
-
Figure East China Recombinant Antibody Consumption Share by Types in 2027
-
Table East China Recombinant Antibody Consumption by End-Users from 2016 to 2027
-
Table East China Recombinant Antibody Consumption Share by End-Users from 2016 to 2027
-
Figure East China Recombinant Antibody Consumption Share by End-Users in 2016
-
Figure East China Recombinant Antibody Consumption Share by End-Users in 2021
-
Figure East China Recombinant Antibody Consumption Share by End-Users in 2027
-
Table Northeast China Recombinant Antibody Consumption by Types from 2016 to 2027
-
Table Northeast China Recombinant Antibody Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Recombinant Antibody Consumption Share by Types in 2016
-
Figure Northeast China Recombinant Antibody Consumption Share by Types in 2021
-
Figure Northeast China Recombinant Antibody Consumption Share by Types in 2027
-
Table Northeast China Recombinant Antibody Consumption by End-Users from 2016 to 2027
-
Table Northeast China Recombinant Antibody Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Recombinant Antibody Consumption Share by End-Users in 2016
-
Figure Northeast China Recombinant Antibody Consumption Share by End-Users in 2021
-
Figure Northeast China Recombinant Antibody Consumption Share by End-Users in 2027
-
Table Southwest China Recombinant Antibody Consumption by Types from 2016 to 2027
-
Table Southwest China Recombinant Antibody Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Recombinant Antibody Consumption Share by Types in 2016
-
Figure Southwest China Recombinant Antibody Consumption Share by Types in 2021
-
Figure Southwest China Recombinant Antibody Consumption Share by Types in 2027
-
Table Southwest China Recombinant Antibody Consumption by End-Users from 2016 to 2027
-
Table Southwest China Recombinant Antibody Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Recombinant Antibody Consumption Share by End-Users in 2016
-
Figure Southwest China Recombinant Antibody Consumption Share by End-Users in 2021
-
Figure Southwest China Recombinant Antibody Consumption Share by End-Users in 2027
-
Table Northwest China Recombinant Antibody Consumption by Types from 2016 to 2027
-
Table Northwest China Recombinant Antibody Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Recombinant Antibody Consumption Share by Types in 2016
-
Figure Northwest China Recombinant Antibody Consumption Share by Types in 2021
-
Figure Northwest China Recombinant Antibody Consumption Share by Types in 2027
-
Table Northwest China Recombinant Antibody Consumption by End-Users from 2016 to 2027
-
Table Northwest China Recombinant Antibody Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Recombinant Antibody Consumption Share by End-Users in 2016
-
Figure Northwest China Recombinant Antibody Consumption Share by End-Users in 2021
-
Figure Northwest China Recombinant Antibody Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of GE Healthcare
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GE Healthcare
-
Figure Sales and Growth Rate Analysis of GE Healthcare
-
Figure Revenue and Market Share Analysis of GE Healthcare
-
Table Product and Service Introduction of GE Healthcare
-
Table Company Profile and Development Status of Abnova
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abnova
-
Figure Sales and Growth Rate Analysis of Abnova
-
Figure Revenue and Market Share Analysis of Abnova
-
Table Product and Service Introduction of Abnova
-
Table Company Profile and Development Status of Medix Biochemica
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Medix Biochemica
-
Figure Sales and Growth Rate Analysis of Medix Biochemica
-
Figure Revenue and Market Share Analysis of Medix Biochemica
-
Table Product and Service Introduction of Medix Biochemica
-
Table Company Profile and Development Status of SinoBiological
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of SinoBiological
-
Figure Sales and Growth Rate Analysis of SinoBiological
-
Figure Revenue and Market Share Analysis of SinoBiological
-
Table Product and Service Introduction of SinoBiological
-
Table Company Profile and Development Status of Bioventix
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bioventix
-
Figure Sales and Growth Rate Analysis of Bioventix
-
Figure Revenue and Market Share Analysis of Bioventix
-
Table Product and Service Introduction of Bioventix
-
